Copyright Reports & Markets. All rights reserved.

Global Bicalutamide Market Status and Forecast 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Bicalutamide Market Status and Forecast (2016-2027)
      • 1.3.2 Global Bicalutamide Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Bicalutamide Supply by Company

    • 2.1 Global Bicalutamide Sales Volume by Company
    • 2.2 Global Bicalutamide Sales Value by Company
    • 2.3 Global Bicalutamide Price by Company
    • 2.4 Bicalutamide Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Bicalutamide Market Status by Type

    • 3.1 Bicalutamide Type Introduction
      • 3.1.1 Tablets
      • 3.1.2 Capsule
    • 3.2 Global Bicalutamide Market by Type
      • 3.2.1 Global Bicalutamide Sales Volume by Type (2016-2021)
      • 3.2.2 Global Bicalutamide Sales Value by Type (2016-2021)
      • 3.2.3 Global Bicalutamide Price by Type (2016-2021)
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Bicalutamide Market Status by Application

    • 4.1 Bicalutamide Segment by Application
      • 4.1.1 Single Drug For Prostate Cancer
      • 4.1.2 Combined Chemotherapy For Prostate Cancer
      • 4.1.3 Combined Radiation Therapy Or Castration For Prostate Cancer
    • 4.2 Global Bicalutamide Market by Application
      • 4.2.1 Global Bicalutamide Sales Volume by Application (2016-2021)
      • 4.2.2 Global Bicalutamide Sales Value by Application (2016-2021)
      • 4.2.3 Global Bicalutamide Price by Application (2016-2021)
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Bicalutamide Market Status by Region

    • 5.1 Global Bicalutamide Market by Region
      • 5.1.1 Global Bicalutamide Sales Volume by Region
      • 5.1.2 Global Bicalutamide Sales Value by Region
    • 5.2 North America Bicalutamide Market Status
    • 5.3 Europe Bicalutamide Market Status
    • 5.4 Asia Pacific Bicalutamide Market Status
    • 5.5 Central & South America Bicalutamide Market Status
    • 5.6 Middle East & Africa Bicalutamide Market Status

    6 North America Bicalutamide Market Status

    • 6.1 North America Bicalutamide Market by Country
      • 6.1.1 North America Bicalutamide Sales Volume by Country (2016-2021)
      • 6.1.2 North America Bicalutamide Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Bicalutamide Market Status

    • 7.1 Europe Bicalutamide Market by Country
      • 7.1.1 Europe Bicalutamide Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Bicalutamide Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Bicalutamide Market Status

    • 8.1 Asia Pacific Bicalutamide Market by Country
      • 8.1.1 Asia Pacific Bicalutamide Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Bicalutamide Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Bicalutamide Market Status

    • 9.1 Central & South America Bicalutamide Market by Country
      • 9.1.1 Central & South America Bicalutamide Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Bicalutamide Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Bicalutamide Market Status

    • 10.1 Middle East & Africa Bicalutamide Market by Country
      • 10.1.1 Middle East & Africa Bicalutamide Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Bicalutamide Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Bicalutamide Manufacturing Cost Analysis
    • 11.5 Bicalutamide Sales Channel and Distributors Analysis
      • 11.5.1 Bicalutamide Sales Channel
      • 11.5.2 Bicalutamide Distributors
    • 11.6 Bicalutamide Downstream Major Buyers

    12 Global Bicalutamide Market Forecast by Type and by Application

    • 12.1 Global Bicalutamide Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Bicalutamide Forecast by Type
      • 12.2.1 Global Bicalutamide Sales Volume Forecast by Type
      • 12.2.2 Global Bicalutamide Sales Value Forecast by Type
      • 12.2.3 Global Bicalutamide Price Forecast by Type
    • 12.3 Global Bicalutamide Forecast by Application
      • 12.3.1 Global Bicalutamide Sales Volume Forecast by Application
      • 12.3.2 Global Bicalutamide Sales Value Forecast by Application
      • 12.3.3 Global Bicalutamide Price Forecast by Application

    13 Global Bicalutamide Market Forecast by Region/Country

    • 13.1 Global Bicalutamide Market Forecast by Region (2022-2027)
      • 13.1.1 Global Bicalutamide Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Bicalutamide Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Zhejiang Haizheng Pharmaceutical
      • 14.1.1 Company Information
      • 14.1.2 Bicalutamide Product Introduction
      • 14.1.3 Zhejiang Haizheng Pharmaceutical Bicalutamide Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Zeneca GmbH
      • 14.2.1 Company Information
      • 14.2.2 Bicalutamide Product Introduction
      • 14.2.3 Zeneca GmbH Bicalutamide Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Sorres Pharma
      • 14.3.1 Company Information
      • 14.3.2 Bicalutamide Product Introduction
      • 14.3.3 Sorres Pharma Bicalutamide Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Sivem Pharmaceuticals
      • 14.4.1 Company Information
      • 14.4.2 Bicalutamide Product Introduction
      • 14.4.3 Sivem Pharmaceuticals Bicalutamide Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Shanxi Zhendong Pharmaceutical
      • 14.5.1 Company Information
      • 14.5.2 Bicalutamide Product Introduction
      • 14.5.3 Shanxi Zhendong Pharmaceutical Bicalutamide Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Shanghai Zhaohui Pharmaceutical
      • 14.6.1 Company Information
      • 14.6.2 Bicalutamide Product Introduction
      • 14.6.3 Shanghai Zhaohui Pharmaceutical Bicalutamide Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Shanghai Fudan Fuhua Pharmaceutical
      • 14.7.1 Company Information
      • 14.7.2 Bicalutamide Product Introduction
      • 14.7.3 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Fresenius Kabi
      • 14.8.1 Company Information
      • 14.8.2 Bicalutamide Product Introduction
      • 14.8.3 Fresenius Kabi Bicalutamide Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 CORDEN PHARMA GMBH
      • 14.9.1 Company Information
      • 14.9.2 Bicalutamide Product Introduction
      • 14.9.3 CORDEN PHARMA GMBH Bicalutamide Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 AstraZeneca
      • 14.10.1 Company Information
      • 14.10.2 Bicalutamide Product Introduction
      • 14.10.3 AstraZeneca Bicalutamide Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 Apotex Corporation
    • 14.12 ANI Pharmaceuticals
    • 14.13 Actavis Pharma
    • 14.14 Accel Pharma

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Bicalutamide market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Bicalutamide industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to this survey, the global Bicalutamide market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Bicalutamide Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Bicalutamide market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Bicalutamide Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Bicalutamide industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      Tablets
      Capsule

      Segmented by Application
      Single Drug For Prostate Cancer
      Combined Chemotherapy For Prostate Cancer
      Combined Radiation Therapy Or Castration For Prostate Cancer

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Sorres Pharma
      Sivem Pharmaceuticals
      Shanxi Zhendong Pharmaceutical
      Shanghai Zhaohui Pharmaceutical
      Shanghai Fudan Fuhua Pharmaceutical
      Fresenius Kabi
      CORDEN PHARMA GMBH
      AstraZeneca
      Apotex Corporation
      ANI Pharmaceuticals
      Actavis Pharma
      Accel Pharma
      Buy now